R Nuti

Author PubWeight™ 53.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study. Bone 2005 1.80
2 Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int 2015 1.46
3 Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol 2005 1.44
4 Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis 2010 1.16
5 Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag 2010 1.15
6 The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int 2008 1.08
7 Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int 2003 1.07
8 Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane. Bone 2006 0.99
9 Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 2001 0.99
10 [Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)]. Reumatismo 2011 0.97
11 Bone ultrasonography at phalanxes in patients with Rett syndrome: a 3-year longitudinal study. Bone 2007 0.96
12 Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study. J Clin Densitom 2009 0.96
13 Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism. J Neurol Sci 1993 0.96
14 Osteoporosis treatment and fracture incidence: the ICARO longitudinal study. Osteoporos Int 2008 0.93
15 Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int 2006 0.93
16 The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer. Eur J Intern Med 2008 0.90
17 Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family. J Med Genet 2003 0.89
18 Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study. Int J Immunopathol Pharmacol 2011 0.89
19 Quantitative ultrasound calcaneous measurements: normative data for the Italian population. the ESOPO study. J Clin Densitom 2007 0.87
20 Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Bone 2006 0.87
21 Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis. Osteoporos Int 2013 0.87
22 [Guidelines for the diagnosis, prevention and treatment of osteoporosis]. Reumatismo 2010 0.85
23 Clinical impact of BNP and other emerging biomarkers in heart failure evaluation and management. Minerva Cardioangiol 2012 0.84
24 Long-term treatment with calcitriol in postmenopausal osteoporosis. Metabolism 1990 0.84
25 Methods and clinical applications of total body absorptiometry. J Nucl Med Allied Sci 1987 0.83
26 Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem 1987 0.82
27 Magnetic resonance imaging in Tietze's syndrome. Clin Exp Rheumatol 2008 0.82
28 Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome. Int J Clin Pract 2007 0.82
29 The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis. J Endocrinol Invest 1984 0.82
30 Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. Osteoporos Int 2004 0.81
31 Choline kinase active site provides features for designing versatile inhibitors. Curr Top Med Chem 2014 0.81
32 Secondary osteoporosis. Aging (Milano) 1998 0.81
33 Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. Calcif Tissue Int 2010 0.81
34 Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis. Calcif Tissue Int 1986 0.80
35 Idiopathic avascular necrosis of the scaphoid. A case report. Recenti Prog Med 1995 0.80
36 Effects of parathyroid hormone and calcitonin on plasma and nephrogenous cyclic adenosine-3',5'-monophosphate in normal subjects and in pathological conditions. Eur J Clin Invest 1980 0.80
37 Leptin and body composition in healthy postmenopausal women. Panminerva Med 2001 0.80
38 Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man. J Steroid Biochem 1981 0.80
39 Efficacy and safety of a musically modulated electromagnetic field (TAMMEF) in patients affected by knee osteoarthritis. Clin Exp Rheumatol 2004 0.79
40 Serum osteocalcin radioimmunoassay in bone diseases. Ric Clin Lab 1986 0.79
41 Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure. Minerva Cardioangiol 2005 0.79
42 Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANK-L) serum levels in patients on chronic hemodialysis. J Endocrinol Invest 2005 0.79
43 Bone loss in men. Calcif Tissue Int 1996 0.79
44 A comparative study of dual-X-ray absorptiometry and quantitative ultrasonography for the evaluating bone status in subjects with Rett syndrome. Calcif Tissue Int 2014 0.79
45 The association of body composition and sex hormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. Calcif Tissue Int 2011 0.78
46 Vitamin D metabolites in postmenopausal osteoporosis. Horm Metab Res 1984 0.78
47 Teriparatide's effects on quantitative ultrasound parameters and bone density in women with established osteoporosis. Osteoporos Int 2006 0.78
48 [Italian guidelines for the diagnosis and treatment of Paget's disease of bone]. Reumatismo 2007 0.78
49 Accuracy of different reduced versions of a validated food-frequency questionnaire in italian men and women. Calcif Tissue Int 2009 0.77
50 Genetics of osteoporosis. Calcif Tissue Int 1994 0.77
51 Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy. J Endocrinol Invest 2009 0.77
52 Relationship between quantitative ultrasound parameters at the calcaneus and health-related quality of life in postmenopausal Italian women: the FEDRO study. Calcif Tissue Int 2013 0.77
53 Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers. Minerva Cardioangiol 2007 0.77
54 Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description. Clin Exp Rheumatol 2010 0.77
55 Increased phospholipase activity in Helicobacter pylori strains isolated from patients with gastric carcinoma. Dig Liver Dis 2005 0.77
56 IgG and IgM antiganglioside M1 antibodies in primary Sjogren's syndrome with and without peripheral neuropathy. Clin Rheumatol 2003 0.77
57 Serum proteome of patients with systemic sclerosis: molecular analysis of expression and prevalence of haptoglobin alpha chain isoforms. Int J Immunopathol Pharmacol 2010 0.77
58 Macitentan slows down the dermal fibrotic process in systemic sclerosis: in vitro findings. J Biol Regul Homeost Agents 2013 0.77
59 The assessment of vertebral fractures in elderly women with recent hip fractures: the BREAK Study. Osteoporos Int 2012 0.77
60 Age-related changes in body composition of healthy and osteoporotic women. Maturitas 1997 0.77
61 Bone ultrasonography in glucocorticoid-induced osteoporosis. Osteoporos Int 2004 0.76
62 The relationship between serum ghrelin and body composition with bone mineral density and QUS parameters in subjects with Rett syndrome. Bone 2012 0.76
63 Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis. Acta Vitaminol Enzymol 1984 0.75
64 Expression of RXFP1 in skin of scleroderma patients and control subjects. Scand J Rheumatol 2012 0.75
65 Immunolocalisation of ghrelin and obestatin in human testis, seminal vesicles, prostate and spermatozoa. Andrologia 2013 0.75
66 Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis. J Biol Regul Homeost Agents 2012 0.75
67 Intestinal radiocalcium transport versus urinary calcium excretion in long-term 1,25(OH)2D3 treatment. J Nucl Med Allied Sci 1986 0.75
68 [The diagnosis of postmenopausal osteoporosis]. Minerva Endocrinol 1992 0.75
69 [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins]. Minerva Med 1983 0.75
70 The 24-h urinary cyclic adenosine 3', 5' monophosphate/creatinine ratio: an useful approach to the diagnosis of parathyroid disorders and function. J Endocrinol Invest 1982 0.75
71 [Functional constipation and its treatment]. Minerva Gastroenterol 1974 0.75
72 Glucocorticoids and intestinal absorption of calcium and phosphate. Adv Exp Med Biol 1984 0.75
73 [Metabolic changes induced with salmon calcitonin in post-menopausal osteoporosis]. Minerva Med 1980 0.75
74 Carbocalcitonin treatment in Sudeck's atrophy. Clin Orthop Relat Res 1987 0.75
75 A case of acute heart failure associated with Guillain-Barré syndrome. Neurol Sci 2006 0.75
76 Pathophysiological aspects of calcium metabolism in spasmophilia. Biomed Pharmacother 1987 0.75
77 [Effects of nandrolone decanoate on bone mineral content and intestinal absorption of calcium]. Minerva Med 1984 0.75
78 Hypercalcemic effect of nifedipine treatment in man. Boll Soc Ital Biol Sper 1977 0.75
79 [Influence of disodium etidronate (EHDP) on plasma and urinary levels of sodium and potassium in humans]. Boll Soc Ital Biol Sper 1975 0.75
80 Haptoglobin phenotypes in systemic sclerosis. Clin Exp Rheumatol 2009 0.75
81 [Sodium etidronate (EHDP) and osteoporosis]. Clin Ter 1981 0.75
82 [Synthetic human calcitonin in Paget's disease of bone and osteoporosis (author's transl)]. Dtsch Med Wochenschr 1981 0.75
83 [Effect of venous infusion of cortisol on the urinary excretion of cyclic AMP in humans]. Boll Soc Ital Biol Sper 1975 0.75
84 Cyclic AMP urinary excretion and radiocalcium intestinal absorption in hypercalciurias. Boll Soc Ital Biol Sper 1977 0.75
85 [An autopsy study of patients who died at the Medical Clinic of the University of Siena from 1986 to 1989]. Recenti Prog Med 1992 0.75
86 Effects of deflazacort on the renal handling of radiocalcium in man. Adv Exp Med Biol 1984 0.75
87 Total body absorptiometry in postmenopausal osteoporosis patients treated with 1 alpha-hydroxylated vitamin D metabolites. Osteoporos Int 1993 0.75
88 Occupational asthma due to colophony in non-industrial environments. Med Lav 1994 0.75
89 A clinical case of drug hypersensivity syndrome with phenobarbital administration: drug-induced rash with eosinophilia and systemic symptoms or lupus-like syndrome? Clin Exp Rheumatol 2007 0.75
90 Early effects of synthetic bovine parathyroid hormone and synthetic salmon calcitonin on urinary excretion of cyclic AMP, phosphate and calcium in man. Calcif Tissue Res 1976 0.75
91 Human calcitonin and malignant osteolysis. Panminerva Med 1986 0.75
92 25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man. J Endocrinol Invest 1984 0.75
93 Gender-specific associations of appendicular muscle mass with BMD in elderly Italian subjects. Calcif Tissue Int 2014 0.75
94 [Correlation between the free thyroxine index and intestinal absorption of radiocalcium in thyroid diseases]. Boll Soc Ital Biol Sper 1976 0.75
95 [Behavior of blood and urinary magnesium in diabetes mellitus]. Boll Soc Ital Biol Sper 1978 0.75
96 [Treatment of Sudeck's syndrome with human calcitonin]. Dtsch Med Wochenschr 1983 0.75
97 [Bone mineral measurement: methodological observations and dosimetric values]. Radiol Med 1980 0.75
98 Effect of a long-term treatment with the aminosuberic analog of eel calcitonin on osteocalcin in Paget's disease. Panminerva Med 1987 0.75
99 Indirect evidence of calcitonin secretion in man. Clin Sci Mol Med 1976 0.75
100 Whole-body retention of 99mTc-MPD in Paget's disease. J Nucl Med Allied Sci 1981 0.75
101 [Behavior of blood calcium after oral administration of glucose in subjects with defective intestinal transport of radiocalcium]. Boll Soc Ital Biol Sper 1976 0.75
102 [Reconstructive surgery of the mitral and tricuspid valves with a Cosgrove-Edwards flexible ring]. Ital Heart J Suppl 2000 0.75
103 [A case of primary chronic osteomyelitis in a rare site (distal metaphysis of the radius)]. Pediatr Med Chir 1986 0.75
104 [Behavior of urinary excretion of cyclic AMP in post-menopausal osteoporosis during therapy with salmon calcitonin]. Minerva Med 1982 0.75
105 Role of the active vitamin D metabolite and 1 alpha-hydroxylated analogs in the treatment of postmenopausal osteoporosis. J Nutr Sci Vitaminol (Tokyo) 1992 0.75
106 Effect of bromocriptine on phosphatemia in acromegaly. Boll Soc Ital Biol Sper 1977 0.75
107 The speed of sound correlates with implant insertion torque in rabbit bone: an in vitro experiment. Clin Oral Implants Res 2010 0.75
108 [Bone mineralometry in post-menopausal osteoporosis]. Minerva Med 1983 0.75
109 Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study. Reumatismo 2017 0.75
110 Central diabetes insipidus with spontaneous remission. A case report. Recenti Prog Med 1998 0.75
111 Perspectives in the treatment and prevention of osteoporosis. Drugs Today (Barc) 2009 0.75
112 Current therapeutic strategies in cardiorenal syndrome. Minerva Cardioangiol 2012 0.75
113 [Bone mineral measurement in Paget's disease]. Boll Soc Ital Biol Sper 1978 0.75
114 [Bone mineral content value (single americium 241 energy source) in diabetes mellitus]. Radiol Med 1980 0.75
115 Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment. Drug Saf 1994 0.75
116 [A case of pseudomembranous colitis in childhood]. Pediatr Med Chir 1994 0.75
117 [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone]. Minerva Med 1982 0.75
118 [Methods for measuring whole-body adipose tissue: the usefulness of "total body" X-ray densitometry]. Minerva Med 1992 0.75
119 [Determination of drug costs in general anesthesia]. Minerva Anestesiol 1992 0.75